Optimal omission of anthracycline in adjuvant chemotherapy of HER2 positive breast cancer R. Watanuki,T. Hayashida, K. Yuko,M. Kikuchi, A. Nakashoji,T. Yokoe, T. Toyota,T. Seki,M. Takahashi, Y. KitagawaCANCER RESEARCH(2019)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要